Bioequivalence Study to Compare Two Injection Devices for BMN 111 in Healthy Participants
Clinical trial NCT05813314 · TERMINATED
Trial details
- NCT number
- NCT05813314
- Sponsor
- BioMarin Pharmaceutical
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-03-15
- Primary completion
- 2023-06-14
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.